Collection of Clinical Data and Specimens for Research in Hearing, Balance and Communication Disorders

Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD) (NIH)
Overall Status
Not yet recruiting
CT.gov ID
NCT05670496
Collaborator
(none)
600
1
117.8
5.1

Study Details

Study Description

Brief Summary

Background:

People with hearing, balance, and communication disorders may seek treatment at the National Institute on Deafness and Other Communication Disorders (NIDCD). Some of these people may benefit from enrolling in the NIDCD intramural research program to receive their care. Enrolling will also allow investigators to collect participants clinical data and specimens for future research.

Objective:

This natural history study has 2 goals: (1) to collect data and specimens that may be used for research; and (2) to evaluate participants who may be candidates for other research studies.

Eligibility:

People aged 2 years or older with a hearing, balance, and communication disorder. Those at risk or who are suspected of having such a disorder are also eligible.

Design:

Participants will be screened. Their medical records will be reviewed.

Participants will agree to have their medical data used for research. Specimens such as blood or other tissue samples may also be used for research. All data and specimens will be collected during their routine care visits.

All tests done will be the normal care for each participant s condition. No tests will be done solely for research.

Some of these tests may require blood or tissue samples. Some may use special tools to test hearing and balance. Some may test heart or lung function. These tests may also include different types of imaging scans.

All tests will be explained. Participants may ask questions at any time.

Participants may remain in this study for up to 2 years. If they need further care, they may sign a new consent.

...

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Study Description:

    It may be in the interest of the NIDCD Clinical Research Program (CRP) to collect clinical data or specimens generated in the diagnosis and treatment of hearing, balance and communication disorders and to evaluate patients to determine candidacy for intramural clinical studies. This protocol will provide the administrative vehicle to enable the evaluation and provision of clinical care for patients with hearing, balance and communication disorders by the NIDCD CRP, Clinical Center, and consult services as well as to provide a repository of information on enrolled subjects to allow for hypothesis generation in future research. No investigational therapies will be administered in this study.

    Objectives:
    • To provide a repository of data and samples collected from clinical data or specimens generated in the diagnosis and treatment of hearing, balance and communication disorders to allow for hypothesis generation in future research.

    • To evaluate patients to determine candidacy for intramural clinical studies

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    600 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Collection of Clinical Data and Specimens for Research in Hearing, Balance and Communication Disorders
    Anticipated Study Start Date :
    Feb 6, 2023
    Anticipated Primary Completion Date :
    Aug 1, 2023
    Anticipated Study Completion Date :
    Dec 1, 2032

    Arms and Interventions

    Arm Intervention/Treatment
    Patients

    Patients at risk, suspected of having, have a history of, or currently have a diagnosed hearing, balance or communication disorder.

    Outcome Measures

    Primary Outcome Measures

    1. Clinical data collection [Ongoing]

      To collect clinical data or specimens generated in the diagnosis and treatment of hearing, balance and communication disorders

    2. Evaluation for clinical studies [Ongoing]

      To evaluate patients to determine candidacy for intramural clinical studies

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    • INCLUSION CRITERIA:

    In order to be eligible to participate in this study, an individual must meet all of the following criteria:

    • Patients must be age 2 years or older if procedures or treatment are required.

    • Patients at risk, suspected of having, have a history of, or currently have a diagnosed hearing , balance and communication disorder.

    • An NIDCD clinical investigator and PI determines it is in the interest of the patient/individual and NIDCD CRP for the subject to undergo consult, treatment or follow-up at the NIDCD/NIHPatient or their Legally Authorized Representative is able to provide informed consent. The consent form will be signed by parents or guardians of patients under the age of 18.

    EXCLUSION CRITERIA:

    An individual who meets any of the following criteria will be excluded from participation in this study:

    • Candidates who do not meet the inclusion criteria.

    • Candidates who in the opinion of the PI and clinical team have medical or unstable conditions for which NIDCD and CC consultative services are unable to provide or support optimal care

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Institutes of Health Clinical Center Bethesda Maryland United States 20892

    Sponsors and Collaborators

    • National Institute on Deafness and Other Communication Disorders (NIDCD)

    Investigators

    • Principal Investigator: Michael Hoa, M.D., National Institute on Deafness and Other Communication Disorders (NIDCD)

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    National Institute on Deafness and Other Communication Disorders (NIDCD)
    ClinicalTrials.gov Identifier:
    NCT05670496
    Other Study ID Numbers:
    • 10001126
    • 001126-DC
    First Posted:
    Jan 4, 2023
    Last Update Posted:
    Feb 1, 2023
    Last Verified:
    Dec 27, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by National Institute on Deafness and Other Communication Disorders (NIDCD)
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 1, 2023